Jon P. Stonehouse
2019
In 2019, Jon P. Stonehouse earned a total compensation of $2.3M as President, Chief Executive Officer and Director at BioCryst Pharmaceuticals, a 45% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $350,625 |
|---|---|
| Option Awards | $1,368,767 |
| Salary | $550,000 |
| Other | $14,905 |
| Total | $2,284,297 |
Stonehouse received $1.4M in option awards, accounting for 60% of the total pay in 2019.
Stonehouse also received $350.6K in non-equity incentive plan, $550K in salary and $14.9K in other compensation.
Rankings
In 2019, Jon P. Stonehouse's compensation ranked 5,267th out of 13,971 executives tracked by ExecPay. In other words, Stonehouse earned more than 62.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,267 out of 13,971 | 62nd |
Division Manufacturing | 1,958 out of 5,701 | 66th |
Major group Chemicals And Allied Products | 692 out of 2,200 | 69th |
Industry group Drugs | 582 out of 1,886 | 69th |
Industry Biological Products, Except Diagnostic Substances | 133 out of 389 | 66th |
Source: SEC filing on March 31, 2020.
Stonehouse's colleagues
We found four more compensation records of executives who worked with Jon P. Stonehouse at BioCryst Pharmaceuticals in 2019.
2019
Megan Sniecinski
BioCryst Pharmaceuticals
Senior Vice President and Chief Business Officer
2019
Yarlagadda Babu
BioCryst Pharmaceuticals
Senior Vice President of Drug Discovery
2019
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2019
Thomas Staab
BioCryst Pharmaceuticals